Differentiation of a myocardial depressant factor present in shock plasma from known plasma peptides and salts.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000032:analysis / Q000097:blood* / Q000494:pharmacology; D001681:Biological Assay; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D002845:Chromatography; D004600:Eledoisin / Q000494:pharmacology; D066298:In Vitro Techniques; D007583:Jejunum / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects; D010455:Peptides / Q000097:blood* / Q000494:pharmacology; D012492:Salts / Q000097:blood*; D012771:Shock, Hemorrhagic / Q000097:blood*; D014667:Vasopressins / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D010455:Peptides; D012492:Salts; D014667:Vasopressins; D000804:Angiotensin II; D004600:Eledoisin; D001920:Bradykinin